Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of 264.8 billion as of November 25, 2025. Its market cap has decreased by -20.84% in one year.

Market Cap

264.80B

Enterprise Value

210.49B

Revenue

49.40B

Ranking

n/a

PE Ratio

16.68

Stock Price

750.80

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 227.80M to 264.80B, an increase of 116,141.71%. That is a compound annual growth rate of 23.55%.

Market Cap History

Date	Market Cap	% Change
Nov 24, 2025	264.80B	-8.39%
Dec 31, 2024	289.05B	-16.66%
Dec 29, 2023	346.85B	18.17%
Dec 30, 2022	293.52B	11.36%
Dec 31, 2021	263.57B	42.98%
Dec 31, 2020	184.34B	35.56%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Banco de Crédito del Perú	61.23B
Sociedad Minera Cerro Verde	53.39B
Unión de Cervecerías Peruanas Backus y Johnston	24.10B
Compañía de Minas Buenaventura	20.33B
Intercorp Financial Services	15.04B
Banco BBVA Perú	14.47B
Minsur	11.96B
Shougang Hierro Peru S.a.a.	10.71B

Market Cap Rankings